# Levothyroxine Sodium

NDC: 66794-201
Generic name: Levothyroxine Sodium
Labeler / Manufacturer: Piramal Critical Care, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20221001

FDA application: ANDA206163

## Active ingredients

- LEVOTHYROXINE SODIUM ANHYDROUS: 500 ug/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66794-201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66794-201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=76139990-1355-cfb6-e053-2991aa0ace5b